Compare PSNL & GCMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PSNL | GCMG |
|---|---|---|
| Founded | 2011 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 729.1M | 731.1M |
| IPO Year | 2019 | N/A |
| Metric | PSNL | GCMG |
|---|---|---|
| Price | $6.33 | $9.95 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | $12.20 | ★ $15.33 |
| AVG Volume (30 Days) | ★ 1.5M | 574.1K |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 4.81% |
| EPS Growth | ★ 33.58 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $69,648,000.00 | N/A |
| Revenue This Year | $15.47 | $7.28 |
| Revenue Next Year | $39.24 | $11.70 |
| P/E Ratio | ★ N/A | $28.21 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.97 | $9.30 |
| 52 Week High | $11.50 | $13.22 |
| Indicator | PSNL | GCMG |
|---|---|---|
| Relative Strength Index (RSI) | 37.27 | 45.08 |
| Support Level | $4.65 | $9.30 |
| Resistance Level | $9.64 | $11.88 |
| Average True Range (ATR) | 0.51 | 0.32 |
| MACD | -0.03 | 0.04 |
| Stochastic Oscillator | 13.68 | 68.21 |
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
GCM Grosvenor Inc is a world-wide alternative asset management firm. It invests on behalf of clients who seek allocations to alternative investments, such as private equity, infrastructure, real estate, credit, ESG and absolute return strategies. Company invest maximum in Private Equity. The company's offerings include multi-manager portfolios as well as portfolios of direct investments and co-investments.